跳至主要内容
临床试验/ISRCTN38158659
ISRCTN38158659已完成不适用

Vitamin D supplementation in the obese: a pilot study

St Vincent's University Hospital (Ireland)0 个研究点目标入组 60 人开始时间: 2012年4月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged between 18 and 65 years
  • 2. Body mass index is greater than 40 kg/m2

排除标准

  • 1. Known hypersensitivity to the active substances or any of the excipients of Caltrate®
  • 2. Known hypersensitivity to soya or to peanut
  • 3. Stage 4 or Stage 5 chronic kidney disease (eGFR < 30 ml/min/1.78m2)
  • 4. Nephrolithiasis
  • 5. Hypercalcaemia (serum calcium concentration > 2.6 mmol/L)
  • 6. Pregnancy
  • 7. Lactation
  • 8. Psychotic mental illness
  • 9. Inability to understand the participant information or to give informed consent
  • 10. Any clinically significant chronic disease that might, in the opinion of the investigator, interfere with the evaluations or preclude completion of the trial (e.g., severe chronic lung disease, terminal illness)
  • 11. Participation in a clinical trial during the 12 weeks prior to study entry (i.e., prior to screening visit)

研究者

发起方
St Vincent's University Hospital (Ireland)

相似试验